| 摘要: |
| ［摘要］ 非小细胞肺癌(non-small cell lung cancer，NSCLC)是病死率最高的恶性肿瘤。微小核糖核酸(micro-ribonucleic acid，miRNA)是一种由18～23个碱基组成的非编码单链小分子RNA，其独特的生物学特性可能使之成为NSCLC的分子诊断和治疗新靶点。该文就miRNA在NSCLC诊断与治疗中的研究概况进行综述。 |
| 关键词: 微小核糖核酸 非小细胞肺癌 诊断 治疗 |
| DOI：10.3969/j.issn.1674-3806.2016.10.35 |
| 分类号:R 734.2 |
| 基金项目: |
|
| Research progress of miRNA in the diagnosis and targeted therapy of non-small cell lung cancer |
|
WEI Si-zun, FENG Jie, ZHOU Ji-hong
|
|
Department of Respiratory Medicine, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning 530011, China
|
| Abstract: |
| ［Abstract］ Non-small cell lung cancer(NSCLC) is one of the malignant tumors with the highest mortality. Micro-ribonucleic acid(miRNA) is a non-coding single-stranded small RNA comprised of 18 to 23 bases. With the unique biological features, it may become a new target for the diagnosis and therapy of NSCLC.The research progress of miRNAs in the diagnosis and targeted therapy of NSCLC is reviewed in this paper. |
| Key words: Micro-ribonucleic acid(miRNA) Non-small cell lung cancer(NSCLC) Diagnosis Therapy |
